Notified Body designation and scope, the impact of Brexit and Competent Authority and Notified Body interpretation of the regulations. Make sure you are up to date!

Update on the EU MDR delay and impact on industry - Panel discussion

Share this article

With confirmation of the EU MDR delay due to COVID-19, MedTech Summit brought together four industry insiders to discuss the update and the impacts it will have on industry. The video discussion features:

  • Gert Bos, Executive Director & Partner at Qserve Group, The Netherlands
  • Annabelle Bruydonckx, Counsel at Simmons & Simmons LLP, Belgium
  • James Whitehead, Patient Safety Medical Device Lead at AstraZeneca, UK
  • Vladimir Murovec, Supervising Associate (Healthcare & Life Sciences) at Simmons & Simmons, Belgium

Rebecca Brady, Senior Conference Producer at Informa Life Sciences, led the discussion, which you can watch in full below (or here):


Share this article